Drug Profile
ONO 2921
Latest Information Update: 18 Dec 2003
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Class Analgesics
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neuropathic pain
Most Recent Events
- 18 Dec 2003 No development reported - Preclinical for Neuropathic pain in Japan (unspecified route)
- 29 Nov 2000 New profile
- 29 Nov 2000 Preclinical development for Neuropathic pain in Japan (Unknown route)